Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas.
Demirkiran C, Greenman M, Bellone S, McNamara B, Hartwich TMP, Manavella D, Mutlu L, Zipponi M, Yang-Hartwich Y, Yang K, Ratner E, Schwartz PE, Coma S, Pachter J, Santin AD.
Demirkiran C, et al. Among authors: schwartz pe.
Gynecol Oncol. 2024 May 3;187:12-20. doi: 10.1016/j.ygyno.2024.04.010. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 38703673